Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official

Why did S&P 500 and Nasdaq ease today? What impact will Tesla’s robotaxi launch have? Why is Fed chair Powell criticized over rates? How will Fed rate cuts affect markets? Why is Applied Materials stock falling? How is Israel-Iran conflict affecting oil prices? What caused Circle stock to surge recently?

Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official

statnews.com/2025/06/20/fda-ouster-top-gene-therapy-official-nicole-verdun-placed-on-leave-after-review-committee-canceled

The ouster of the Food and Drug Administration’s chief regulator of cell and gene therapies earlier this week came immediately after a disagreement with her boss over the review of a cell therapy for Duchenne muscular dystrophy, STAT has learned.
The regulator, Nicole Verdun, had…

This story appeared on statnews.com, 2025-06-20 18:05:24.297000.